Sign in

NCT06814041Active, not recruiting

Pilot RCT and Interview Study on an HIV Chatbot in Nigeria

A Pilot Randomized Controlled Trial and an Interview Study to Evaluate a Chatbot for People Living With HIV in Nigeria

Source: ClinicalTrials.gov · Last updated 22 Apr 2026

Brief summary (registry, in English)

This study will investigate the use of a HIV chatbot that acts as an informational coach. The main question the study aims to answer is: Does the chatbot improve HIV knowledge in adults (older than 18-years) newly diagnosed with HIV in Nigeria - compared to a control group? Moreover, the study will also determine potential effects of the chatbot use on patients' resilience, psychological well-being. The study will explore patients' use and perceptions of the chatbot, as well as potential gender differences. The control group will receive Standard of Care only. Patients in the chatbot intervention group will interact with the chatbot in addition to receiving Standard of Care. They will be able to: * Use a chatbot via WhatsApp * Receive information on relevant HIV topics * Get automated responses to their HIV-related questions * Be reminded of medical appointments and medication schedules

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
314 (estimated)
First submitted
3 Feb 2025
Start date
14 Apr 2025
Primary completion date
11 Feb 2026
Lead sponsor
Christoph Pimmer
Diseases
HIV
NCT number
NCT06814041

What you commit to

  • Study type: Interventional
  • Planned participants: 314
  • From 14 Apr 2025 to the primary completion date, 11 Feb 2026
  • 6 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Known pregnancy or ≤3 months postpartum
  • Persons with suicidal ideation and/or severe mental distress

Who the study is looking for

  • Diagnosed with HIV
  • ART enrollment: at the day of recruitment or in the subsequent 7 days. But no longer than 30 months prior to enrolment in the study..
  • Age ≥ 18 years
  • Have a personal internet-enabled smartphone with WhatsApp installed
  • Carry the phone with them at the time of recruitment
  • Able to understand, read, and write in English (the official language in Nigeria)
  • Able to understand the information about the study
  • Provide written informed consent.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (6)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
St. Mary's Catholic General Hospital
Coordinator of this site? Confirm its status
IbadanNigeriaUnknown status
Our Lady of Apostle Catholic Hospital
Coordinator of this site? Confirm its status
IbadanNigeriaUnknown status
Adeoyo Maternity Teaching Hospital
Coordinator of this site? Confirm its status
IbadanNigeriaUnknown status
Infectious Disease Institute, (IDI) UCH
Coordinator of this site? Confirm its status
IbadanNigeriaUnknown status
Ring Road State Hospital
Coordinator of this site? Confirm its status
IbadanNigeriaUnknown status
Baptist Medical Centre
Coordinator of this site? Confirm its status
SakiNigeriaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.